Abstract
Objective: To assess the association between different antihypertensive drug regimens and plasma lipid levels in the general population.
Methods: The Monitoring Project on Cardiovascular Risk Factors was conducted from 1987 to 1991 as a cross-sectional study in The Netherlands. Antihypertensive drug-users and untreated hypertensives were selected. After exclusion of users of cholesterol-lowering drugs 2997 subjects remained for the analysis. The plasma lipid concentrations of the users and non-users of antihypertensives were compared by multiple linear regression.
Results: In the univariate analysis patients using beta-blockers had lower high-density lipoprotein (HDL) concentrations (1.13 mmol/l, P < 0.05) and higher cholesterol ratios (5.74, P < 0.05) than untreated hypertensives (Total cholesterol = 6.07 mmol/l, HDL = 1.20 mmol/l and ratio = 5.44). Patients using diuretics had higher total cholesterol levels (6.34 mmol/l) and higher HDL levels (1.26 mmol/l) compared to untreated hypertensives. After adjustment for possible confounders these differences were smaller and no longer statistically significant. After adjustment we found a significant lower HDL cholesterol (mean difference of −0.10 mmol/l, P < 0.05) for users of a combination of a beta-blocker and a diuretic.
Conclusions: Although randomised, controlled trials have demonstrated that antihypertensive drugs may influence plasma lipid levels we observed no substantial association for single antihypertensive drug therapy in the general population. The combination of a diuretic and a beta-blocker was associated with a worse lipid profile.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kasiske BL, Ma JZ, Kalil RSN, Louis TA Effects of antihypertensive therapy on serum lipids Ann Intern Med 1995 122 133–141
Lakshman MR et alDiuretics and β-blockers do not have adverse effects at 1 year on plasma lipid and lipoprotein profiles in men with hypertension Arch Intern Med 1999 159 551–558
Moser M Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA 1998 279 1813–1816
Howes LG, Lykos D, Rennie GC Effects of antihypertensive drugs on coronary artery disease risk; a meta analysis Clin Exper Pharmacol Physiol 1996 23 555–558
Dimmitt SB, Williams PD, Croft KD, Beilin LJ Effects of beta-blockers on the concentration and oxidizability of plasma lipids Clin Sci Colch 1998 94 573–578
Fogari R et alBeta-blocker effects on plasma lipids during prolonged treatment of hypertensivepatients with hypercholesterolemia J Cardiovasc Pharmacol 1999 33 534–539
Weidman P, Courten de M, Ferrari P, Bohlen L Serum lipoproteins during treatment with antihypertensive drugs J Cardiovasc Pharmacol 1993 22 (Suppl 6) S98–S105
Grimm RH et alLong-term effects on plasma lipids of diet and drugs to treat hypertension JAMA 1996 275 1549–1556
Strickland D, Sprafka JM, Luepker RV, Grimm RH Jr Association of antihypertensive agents and blood lipids in a population-based survey Epidemiology 1994 5 96–101
Hense HW, Doring A, Stieber J, Keil U The association of antihypertensive treatment patterns and adverse lipid effects in population-based studies J Clin Epidemiol 1992 45 1423–1430
Helmert U, Shea S Antihypertensive treatment and serum cholesterol: results of population-based surveys in the German Cardiovascular Prevention Study Rev Environ Health 1997 12 253–260
Goode GK, Miller JP, Heagerty AM Hyperlipidaemia, hypertension, and coronary heart disease Lancet 1995 345 362–364
Klungel OH et alUndertreatment of hypertension in a population-based study in The Netherlands J Hypertens 1998 16 1371–1378
Verschuren WMM et alCardiovascular disease risk factors in The Netherlands Netherlands J Cardiol 1993 6 205–210
Klungel OH et alAgreement between self-reported antihypertensive drug use and pharmacy records in a populationbased study in the Netherlands Pharm World Sci 1999 21 217–220
Weir MR, Flack JM, Applegate WB Tolerability, safety and quality of life and hypertensive therapy: the case for low-dose diuretics Am J Med 1996 101 (Suppl 3A) 83S–93S
Psaty BM et alHealth outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis JAMA 1997 277 739–745
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Maitland-van der Zee, A., Klungel, O., Kloosterman, J. et al. The association between antihypertensive drug therapies and plasma lipid levels in the general population. J Hum Hypertens 15, 701–705 (2001). https://doi.org/10.1038/sj.jhh.1001197
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001197
Keywords
This article is cited by
-
Hypertension and Dyslipidemia Combined Therapeutic Approaches
High Blood Pressure & Cardiovascular Prevention (2022)
-
Blood Pressure Responses and Metabolic Effects of Hydrochlorothiazide and Atenolol
American Journal of Hypertension (2012)
-
Self-blood-pressure monitoring—a questionnaire study: response, requirement, training, support-group popularity and recommendations
Journal of Human Hypertension (2003)